Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma.

Published in: BioMed research international (2020)

Based on these results, we believe that the ACE inhibitor will be important to increase the lifespan of ccRCC patients. This study is the first research to offer a recommendation on the use of anti-hypertensive drugs to ccRCC patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
blood pressure
renal cell carcinoma
sars cov
prognostic factors
coronavirus disease
emergency department
angiotensin ii
patient reported outcomes
binding protein
respiratory syndrome coronavirus